Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease
Open Access
- 1 October 2013
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 54 (10) , 2884-2897
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Effect of Different Phospholipids on α-Secretase Activity in the Non-Amyloidogenic Pathway of Alzheimer’s DiseaseInternational Journal of Molecular Sciences, 2013
- Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional studyAlzheimer's Research & Therapy, 2012
- Docosahexaenoic Acid Signalolipidomics in Nutrition: Significance in Aging, Neuroinflammation, Macular Degeneration, Alzheimer's, and Other Neurodegenerative DiseasesAnnual Review of Nutrition, 2011
- Lipid composition influences the release of Alzheimer's amyloid β‐peptide from membranesProtein Science, 2011
- Secretory phospholipase A2 type III enhances α-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidityJournal of Lipid Research, 2010
- The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluidFluids and Barriers of the CNS, 2009
- Lipidomic analysis of endocannabinoid metabolism in biological samplesJournal of Chromatography B, 2009
- Update of the LIPID MAPS comprehensive classification system for lipidsJournal of Lipid Research, 2009
- Altered Lipid Metabolism in Brain Injury and Disorders2008
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959